CDT Equity Inc. Common Stock (CDT) Stock Price
CDTStock
$2.05−99.93%52W
Market Cap$1.61M
P/E—
PEG Ratio—
Div yield—
Beta1.53
CDT Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-110.29%
Price vs S&P 500 (4W)-18.36%
VGM Score2.00
Industry Peers — Pharmaceuticals(571)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CDTCDT Equity Inc. Common Stock | — | — | F | $2.05 |
| LLYEli Lilly & Co. | D | B | B | $1233.66 |
| JNJJohnson & Johnson | D | C | B | $273.14 |
| ABBVABBVIE INC. | D | C | B | $265.79 |
| MRKMerck & Co., Inc. | D | C | A | $156.45 |
| NVSNovartis AG | C | C | C | $159.98 |
| AZNAstraZeneca PLC | C | B | C | $169.66 |
| NVONovo-Nordisk A/S | B | C | C | $48.66 |
| ABTAbbott Laboratories | C | C | B | $116.13 |
| PFEPfizer Inc. | C | D | C | $28.57 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $552.85 |
About CDT Equity Inc. Common Stock
CDT Equity Inc. is a biopharmaceutical development company that uses artificial intelligence and advanced chemistry to identify and accelerate the development of novel therapeutic treatments. The company creates shareholder value by licensing assets, pursuing strategic acquisitions, and repositioning high-potential drug candidates to market faster. Operating as an agile platform-based model, CDT focuses on transformative innovation across its therapeutic portfolio.